Tounjian Advisory Partners’s Zimmer Biomet ZBH Stock Holding History

Tounjian Advisory Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.15K	Buy	+37	New	+$3.24K	﹤0.01%	517

Other funds holding ZBH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EIC

Equity Investment Corp Atlanta, Georgia $5.24B AUM 11.32% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Tounjian Advisory Partners's ZBH Position: Q2 2026 in Review

Tounjian Advisory Partners opened a new position in Zimmer Biomet (ZBH) in Q2 2026: 37 shares worth $3.15K. The stake represents ﹤0.01% of the portfolio and ranks #517 among its holdings.

534 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Tounjian Advisory Partners held 37 shares of Zimmer Biomet worth $3.15K as of Q2 2026.
Zimmer Biomet was a new Tounjian Advisory Partners position in Q2 2026.
Zimmer Biomet made up ﹤0.01% of Tounjian Advisory Partners's portfolio in Q2 2026, its #517 holding.
534 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Tounjian Advisory Partners's 13F filing for Q2 2026, filed 7 Aug 2026.